Birabaharan M - Search Results

1

Dipeptide-Based Metabolic Labeling of Bacterial Cells for Endogenous Antibody Recruitment.

Fura JM, Pidgeon SE, Birabaharan M, Pires MM. Fura JM, et al. Among authors: birabaharan m. ACS Infect Dis. 2016 Apr 8;2(4):302-309. doi: 10.1021/acsinfecdis.6b00007. Epub 2016 Feb 2. ACS Infect Dis. 2016. PMID: 27294199 Free PMC article.

2

Metabolic Profiling of Bacteria by Unnatural C-terminated D-Amino Acids.

Pidgeon SE, Fura JM, Leon W, Birabaharan M, Vezenov D, Pires MM. Pidgeon SE, et al. Among authors: birabaharan m. Angew Chem Int Ed Engl. 2015 May 18;54(21):6158-62. doi: 10.1002/anie.201409927. Epub 2015 Apr 1. Angew Chem Int Ed Engl. 2015. PMID: 25832713

3

Atrial Fibrillation after RSV Vaccination Among Older Adults.

Birabaharan M, Johns ST, Kaelber DC, Martin TCS, Mehta SR. Birabaharan M, et al. Clin Infect Dis. 2024 Dec 26:ciae649. doi: 10.1093/cid/ciae649. Online ahead of print. Clin Infect Dis. 2024. PMID: 39724318

4

Gut-derived PPAR-γ signaling and risk of bacterial enteric infection: insight from thiazolidinedione users in a US population-based study.

Birabaharan M, Kaelber DC, Nizet V, Zarrinpar A. Birabaharan M, et al. medRxiv [Preprint]. 2024 Dec 2:2024.09.24.24313682. doi: 10.1101/2024.09.24.24313682. medRxiv. 2024. PMID: 39398997 Free PMC article. Preprint.

5

A case of Staphylococcus epidermidis osteomyelitis in the absence of spine hardware.

Coonahan E, Shahrvini B, Birabaharan M, Farid N, Cowell A. Coonahan E, et al. Among authors: birabaharan m. IDCases. 2024 Jan 11;35:e01928. doi: 10.1016/j.idcr.2024.e01928. eCollection 2024. IDCases. 2024. PMID: 38303732 Free PMC article.

6

Reply to Montastruc et al.

Birabaharan M, Martin TCS, Mehta SR. Birabaharan M, et al. Clin Infect Dis. 2023 Jun 8;76(11):2045. doi: 10.1093/cid/ciad091. Clin Infect Dis. 2023. PMID: 36804684 No abstract available.

7

Cardiovascular Outcomes After Tixagevimab and Cilgavimab use for Pre-Exposure Prophylaxis Against Coronavirus Disease 2019: A Population-Based Propensity-matched Cohort Study.

Birabaharan M, Hill E, Begur M, Kaelber DC, Martin TCS, Mehta SR. Birabaharan M, et al. Clin Infect Dis. 2023 Apr 17;76(8):1500-1503. doi: 10.1093/cid/ciac894. Clin Infect Dis. 2023. PMID: 36380460 Clinical Trial.

8

Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19.

Birabaharan M, Martin TCS. Birabaharan M, et al. Am J Emerg Med. 2022 Nov;61:235.e5-235.e6. doi: 10.1016/j.ajem.2022.08.012. Epub 2022 Aug 6. Am J Emerg Med. 2022. PMID: 35970690 Free PMC article.

9

Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.

Birabaharan M, Kaelber DC, Orme CM, Paravar T, Karris MY. Birabaharan M, et al. Br J Dermatol. 2022 Aug;187(2):271-273. doi: 10.1111/bjd.21240. Epub 2022 May 24. Br J Dermatol. 2022. PMID: 35279833 Free PMC article. No abstract available.

10

Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study.

Birabaharan M, Kaelber DC, Pettus JH, Smith DM. Birabaharan M, et al. Diabetes Obes Metab. 2022 Jun;24(6):1176-1179. doi: 10.1111/dom.14659. Epub 2022 Feb 15. Diabetes Obes Metab. 2022. PMID: 35112782 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters